ALKBH5 and melanoma: Li et al., 2020 [13] explained the role of another m6A-eraser protein ‘ALKBH5’ in progression of melanoma-associated metastatic cancer, and enlightened the molecular mechanism to overcome anti-PD-1 resistance by targeting ALKBH5.